会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 41. 发明授权
    • 면역 치료 및 위암 치료제에 대한 효능 및 독성 평가를 위한 마우스 위암 세포주
    • 用于测试免疫抑制剂和胃癌药物的功效和毒性的MURINE GASTRIC CANCER细胞系
    • KR101456627B1
    • 2014-11-03
    • KR1020130045644
    • 2013-04-24
    • 국립암센터
    • 김학균박준원장석훈
    • A01K67/027C12N5/16G01N33/15
    • G01N33/5011A01K2267/0331
    • 본 발명은 면역 치료 및 위암 치료제에 대한 효능 및 독성 평가 또는 전이 억제 유전자의 발굴 및 억제제의 개발을 위한, 자연발생 위암 동물모델 및 이로부터 수립된 위암 세포주에 관한 것이다. 구체적으로, 본 발명의 위암 동물모델 및 이로부터 수립된 위암 세포주는 조직병리학적 특징이 인체 위암과 유사하고, 항암활성이 있는 4-1BB 억제제에 의해 암세포의 크기가 줄어드는 것을 확인함으로써, 면역 치료 및 위암 치료제에 대한 효능 및 독성 평가에 유용하게 사용될 수 있음을 확인하였다. 또한, 본 발명의 위암 세포주 중 하나는 전이가 빠르기 때문에 다른 세포주들과 유전자 발현을 비교하여, 전이에 관련하는 유전자를 발굴하고 전이 억제제의 개발 및 효능평가에 유용하게 사용할 수 있다. 따라서, 본 발명의 위암 동물모델 및 위암 세포주는 면역억제 마우스를 대신하여 위암 억제제 및 위암 전이 억제제의 효능평가 및 면역치료제(immunotherapy) 평가에 유용하게 사용될 수 있음을 확인하였다.
    • 本发明涉及用于评价免疫治疗剂和胃癌治疗剂的功效和毒性,或用于检测转移抑制基因和发展的自发性胃癌和胃癌细胞系的动物模型 的转移抑制剂。 具体而言,根据本发明,胃癌的动物模型和由其衍生的胃癌细胞系的组织病理学特征与人胃癌相似,已经证实胃癌细胞系的癌细胞的大小为 由具有抗癌活性的4-1BB抑制剂减少。 因此,已经证实胃癌细胞系实际上可用于评价免疫治疗剂和胃癌治疗剂的功效和毒性。 此外,本发明的胃癌细胞系之一快速转移,可以通过与其他胃癌细胞系相对于基因表达进行比较来检测转移相关基因。 此外,转移相关基因可以实际用于开发转移抑制剂,并评价转移抑制剂的功效。 因此,根据本发明,已经证实,可以实际使用胃癌和胃癌细胞系代替免疫抑制小鼠的动物模型来评价胃癌抑制剂和胃癌转移抑制剂的功效, 以评估免疫治疗剂的功效。
    • 42. 发明公开
    • 대장암 진단 장치
    • 用于诊断彩色癌症的装置
    • KR1020140057688A
    • 2014-05-13
    • KR1020120134825
    • 2012-11-26
    • 국립암센터
    • 유병철김경희김대용김인후박지원오재환이준화
    • G01N27/62G01N33/574H01J49/26
    • The present invention provides a colorectal cancer diagnostic device for confirming low mass ion to diagnose colorectal cancer through biostatics analysis of low mass ion extracted from a biological sample, and for diagnosing colorectal cancer by using a mass spectrum of the low mass ion. The present invention provides a discriminant for discriminating a colorectal cancer patient group from a non-patient group. In other words, the present invention provides a discriminant for showing an excellent discriminative performance for not only a training group for drawing a discriminant, but also an independent verification group, and the colorectal cancer diagnostic device for diagnosing colorectal cancer by confirming the low mass ions.
    • 本发明提供一种结肠直肠癌诊断装置,用于通过生物样品提取的低质量离子的生物分析分析确认低质量离子以诊断结肠直肠癌,并且通过使用低质量离子的质谱来诊断结肠直肠癌。 本发明提供了用于区分结直肠癌患者组与非患者组的判别式。 换句话说,本发明提供了一种判别式,用于显示不仅用于绘制判别式的训练组,还有独立的验证组以及用于通过确认低质量离子来诊断结肠直肠癌的结肠直肠癌诊断装置的优异的鉴别性能 。
    • 45. 发明公开
    • 선형 삽입깊이 측정장치
    • 测量插入深度的装置
    • KR1020140042138A
    • 2014-04-07
    • KR1020120108485
    • 2012-09-28
    • 국립암센터
    • 김광기손대경손재범정현철
    • A61B1/005A61B1/012
    • The present invention relates to an apparatus for measuring a linear insertion depth. In an apparatus for measuring a linear insertion depth which is used for a test or a procedure, the present invention includes an insertion part which is installed with a constant distance in the longitudinal direction of a magnetic material; and a sensor part which includes a hole sensor of measuring the magnetic field change of the magnetic material installed in the insertion part while the insertion part passes. The insertion depth of a place in or out the human body of the insertion part can be accurately measured by the sensing of the insertion part by the hole sensor and it is harmless to the human body.
    • 本发明涉及一种用于测量线性插入深度的装置。 在用于测试或程序的用于测量线性插入深度的装置中,本发明包括在磁性材料的纵向上以恒定距离安装的插入部分; 以及传感器部,该传感器部具有在插入部通过时测定安装在插入部的磁性材料的磁场变化的孔传感器。 可以通过孔传感器对插入部的感测来精确地测量插入部的人体内外的位置的插入深度,并且对人体无害。
    • 48. 发明公开
    • 위암 진단 및 치료를 위한 ADCY3의 용도
    • 使用ADCY3进行胃癌诊断和治疗
    • KR1020140011710A
    • 2014-01-29
    • KR1020120078443
    • 2012-07-18
    • 국립암센터
    • 이연수고성호김인후홍승현
    • C12Q1/68G01N33/574C12N15/11
    • C12Q1/6886C12N15/1137C12N2310/14C12Q1/527C12Q2600/154C12Q2600/158C12Y406/01001G01N33/57446G01N33/15
    • The present invention relates to: a composition for detecting a gastric cancer marker comprising a pharmaceutical preparation for measuring the of mRNA of ADCY3, or the expression level or the methylation level thereof; a kit for diagnosing gastric cancer, containing the composition; a method for detecting a ADCY3 polynucleotide or a ADCY3 protein for diagnosing gastric cancer by treating a biological sample with the pharmaceutical preparation to ascertain whether a material for complementarily binding to the preparation exists or not and to compare the amount thereof with a control group; and a composition for treating and preventing gastric cancer, containing a preparation capable of inhibiting an ADCY3 polynucleotide or an ADCY3 polypeptide. If the ADCY3 of the present invention is used as a marker for diagnosing gastric cancer, it has high diagnostic sensitivity and specificity, and thereby, having advantages of capable of remarkably contributing to reducing mortality caused by gastric cancer. Furthermore, using the preparation capable of controlling the expression of ADCY3 of the present invention can be applied to preventing and treating gastric cancer.
    • 本发明涉及:用于检测胃癌标志物的组合物,其包含用于测量ADCY3的mRNA的药物制剂,或其表达水平或甲基化水平; 用于诊断胃癌的试剂盒,含有该组合物; 用于通过用药物制剂处理生物样品来检测用于诊断胃癌的ADCY3多核苷酸或ADCY3蛋白的方法,以确定是否存在与该制剂互补结合的材料,并将其与对照组进行比较; 以及含有能够抑制ADCY3多核苷酸或ADCY3多肽的制剂的治疗和预防胃癌的组合物。 如果将本发明的ADCY3用作诊断胃癌的标记物,则其具有高诊断灵敏度和特异性,因此具有能够显着有助于降低胃癌引起的死亡率的优点。 此外,使用能够控制本发明的ADCY3的表达的制剂可以应用于预防和治疗胃癌。
    • 50. 发明公开
    • 수용성 고분자를 포함하는 검체 시료의 응집용 조성물
    • 用于聚合包含水溶性聚合物的生物样品的组合物
    • KR1020130136344A
    • 2013-12-12
    • KR1020120060073
    • 2012-06-04
    • 국립암센터
    • 송강원
    • G01N1/28G01N33/48
    • The present invention relates to a composition for aggregating a biological specimen, a paraffin block manufacturing method using the composition, and a microscopic observing method of the biological specimen using a paraffin block, more particularly, to a composition for aggregating a biological specimen which is composed of a first composition containing water-soluble polymer and distilled water, and a second composition containing organic solvents, such as acetone, and adhesives for medical use, such as cyanoacrylate, and a paraffin block manufacturing method using the composition, and a microscopic observing method of the biological specimen using the manufactured paraffin block. When the paraffin block is manufactured using tissues or cells which are a small amount of the fluidic specimen, a biological specimen complex is manufactured inside a centrifugal tube using a centrifugal separator, thereby minimizing the loss of the specimen, reducing background dyeing, easily manufacturing the paraffin block, saving time and costs required to manufacture the paraffin block, and increasing the quality of a slide cold-hearted from the paraffin block. [Reference numerals] (1) Fix a biological specimen;(2) After centrifugation;(3) Add a first composition;(4) Add a second composition;(5) Centrifugation;(6) Remove supernatant
    • 本发明涉及一种用于聚集生物样品的组合物,使用该组合物的石蜡块制造方法和使用石蜡块的生物样品的显微镜观察方法,更具体地,涉及一种组合生物样品的组合物 含有水溶性聚合物和蒸馏水的第一组合物和含有有机溶剂如丙酮的第二组合物和用于医疗用途的粘合剂如氰基丙烯酸酯和使用该组合物的石蜡块制造方法和显微观察方法 的生物样品。 当使用少量流体样本的组织或细胞制造石蜡块时,使用离心分离器在离心管内制造生物样品复合体,从而使样品的损失最小化,减少背景染色,容易制造 石蜡块,节省制造石蜡块所需的时间和成本,以及提高石蜡块冷心的载玻片的质量。 (1)固定生物样品;(2)离心后;(3)添加第一组合物;(4)添加第二组合物;(5)离心;(6)除去上清液